In a business environment where information is the key to success, where personalized and quality customer service is the basis for a long term and fruitful business relationship, where flexibility in all levels is necessary to adapt to the ever-changing dynamics of the market, in a highly competitive and specialized sector where a global picture of the market is necessary in order to take into account all its complex parameters, we built our company based on 4 key elements:
Experience
IASPIS is characterized by the freshness and the drive of the newly formed company but its core management team carries with it a very important accumulated experience and practice in the pharmaceutical intelligence sector. Amongst other achievements, in their long professional careers, members of our staff have created the initial pharmaceutical intelligence reports for more than 30 countries and produced reports focusing on many aspects of the industry activity. IASPIS P.B.I.'s Consulting and Services team, with over 15 years of experience in servicing the most unstable and unregulated markets in Europe, Asia and Africa, has the capability to offer Intelligence Services focusing on the most unexplored and challenging Pharmaceuticals Markets in the world. Our experience allows us to take into account not only sales and other data that we collect from the market but also other important political, legislative and economical factors that could greatly influence our customer's strategic thinking and planning.
Technical expertise
IASPIS P.B.I.'s staff has a deep knowledge of all the aspects of the Pharmaceutical industry, starting from the production and moving on to the registration and distribution of pharmaceutical products. This expertise allows us to obtain and exploit crucial information for our customer's benefit. It has also allowed us to develop specialized software tools to collect, manipulate, analyze and report pharmaceutical related data.
Flexibility – Tailor made solutions
This is the quality that more than any other differentiates us from the other players in this business. In IASPIS P.B.I. we always try to understand the specific need of our customer and provide tailor made solutions to fulfill it. Flexibility characterizes also our pricing strategy, providing intelligence to large, medium and even small companies in the pharmaceutical industry. Finally, using our proprietary technology, we offer our clients software reporting tools allowing maximum flexibility and adaptability to their specific requirements.
Customer Service
In IASPIS P.B.I., we are fully committed in assuring the optimum value for money to our customers. We consider each customer as a distinct project with its specific requirements and characteristics, totally personalizing our products and services. Additionally, each new customer receives an on-site training session that will allow him to fully exploit the potentials of our software tools. Furthermore a hotline available 24/7 will answer to any questions and assist our customers in any way possible.
Our mission is to become, within the pharmaceutical sector, our customers' best and most needed partner, providing them the intelligence tools that will assist them in their scientific, strategic and marketing decision making process.
What we do
Drug sales and consumption reporting IASPIS P.B.I. collects, processes and reports sales data from pharmacies and consumption data from hospitals. Using our proprietary software tools and our extensive experience in this field, we are able to create reports that statistically reflect the totality of the Greek market. Moreover, we have created a web-based user friendly environment where our customers are able to retrieve the information they need in the most suitable format. Working on the Greek market, we have produced the first pilot reports and our first products will be available soon.
Ad-hoc intelligence projects
IASPIS P.B.I. has the ability to process whatever data a customer has in hand. Processing existing data, enriching it with new one and bringing it to the most suitable form for our customer's purpose, is some of the things we can do for you. We can also start an intelligence project from scratch. Setting goals, parameters and methodology, we can collect process and report marketing data on any matter within the pharmaceutical sector.
Drug Reference Index (DRI)
Drug Reference Index is the first complete Greek catalogue of its kind. Using as a basis the English MIMS, DRI contains SPC information for almost all the drugs sold or consumed in Greece and its use is restrained only to healthcare professionals. DRI's graphic layout and content selection was carried out from our scientific team in collaboration with focus groups of doctor and pharmacists. DRI is available in printed version (DRI 2009) and web-based version (DRIonline).
DRI 2009
DRI is printed every year with updates for all the new drugs and SPC changes in existing ones. DRI 2009 was printed in 11.000 copies and was distributed to doctors and pharmacists by pharmaceutical companies. A large number of copies was distributed free of charge to medical schools and remote community clinics by IASPIS P.B.I.
DRI online
DRIonline is our web-based version of DRI where healthcare professionals can consult drugs' entire SPCs and prices. Our database is constantly updated with changes in existing SPCs and new drugs as well as changes in prices. DRIonline offers a user-friendly environment with useful tools like the intelligent search box and the automatic notification for changes in therapeutic categories of your interest.
- ABBOTT LABORATORIES
- ASTELLAS PHARMA
- ASTRAZENECA
- CANA
- LAVIPHARM
- LEO PHARMACEUTICALS
- NOVARTIS HELLAS
- NOVO NORDISK HELLAS
- PFIZER
- PHARMASERVE LILLY
- ROCHE HELLAS
- ROTTAPHARM HELLAS
- SOLVAY PHARMA
- UCB PHARMA
Collaborating companies* (alphabetically)
ADELCO, ALCON LABORATORIES, ARRIANI PHARMACEUTICALS, ASTELLAS PHARMA, ASTRAZENECA, BAYER HELLAS, BOEHRINGER INGELHEIM, CANA, CHIESI HELLAS, DEMO, ELPEN PHARMACEUTICAL, FARAN, GAP, GENEPHARM, GENESIS PHARMA, GENZYME HELLAS, GILEAD SCIENCES HELLAS, GLAXOSMITHKLINE, HELP, INTENDIS, INTERMED, JANSSEN-CILAG PHARMACEUTICAL, KITE HELLAS, LEO PHARMACEUTICALS, LUNDBECK HELLAS, MEDA PHARMACEUTICALS, MENARINI HELLAS, MERCK-SERONO, MERCK SHARP DOHME, MINERVA, NEXUS, NOVARTIS HELLAS, NOVO NORDISK HELLAS, ORGANON HELLAS, PFIZER HELLAS, PHARMA FABRE, PHARMATHEN, PNG GEROLYMATOS, RECORDATTI, ROCHE HELLAS, ROTTAPHARM HELLAS, SANOFI AVENTIS, SCHERING AG, SCHERING PLOUGH, SCHWARZ PHARMA, SERVIER HELLAS, SOLVAY PHARMA, SPECIFAR, UNI-PHARMA, VELTIPHARM, VERISFIELD, VIANEX, VILCO, WYETH HELLAS.
*Companies that collaborate by sending us their drugs SPCs or PILs and keeping on open line of communication and data exchange.
Nick Kazantzaki 49, 145 64 - Kifisia
Athens, Greece
tel: +30 210 8137049
fax: +30 210 8137132
e-mail: info@iaspis-pbi.com
DRIonline is our web-based version of DRI where healthcare professionals can consult drugs’ entire SPCs and prices. Our database is constantly updated with changes in existing SPCs and new drugs as well as changes in prices. DRIonline offers a user-friendly environment with useful tools like the intelligent search box and the automatic notification for changes in therapeutic categories of your interest.
DRI is printed every year with updates for all the new drugs and SPC changes in existing ones. DRI 2009 was printed in 11.000 copies and was distributed to doctors and pharmacists by pharmaceutical companies. A large number of copies was distributed free of charge to medical schools and remote community clinics by IASPIS P.B.I